Micro Interventional Devices (MID) was founded in 2010. MID is an emerging medical device company that designs, manufactures and commercializes products for transcatheter cardiac repair (TCR) procedures, replicating established surgical structural heart repair procedures percutaneously, providing surgical efficacy with transcatheter safety.
Our technology enables the transformation from open surgical procedures to transcatheter cardiac repair (TCR) procedures.
The Company strives to improve outcomes by:
• Eliminating the need for open-heart surgery
• Eliminating the need for cardiopulmonary bypass
• Reducing procedure time
• Reducing hospital stay and recovery time
While the applications of the technology are broad, Micro Interventional Devices' initial focus is on addressing significant unmet needs in transcatheter mitral and tricuspid valve repair.
MID's headquarters is located in Newtown, Pennsylvania.
Qualified Team and Infrastructure!
The Company is ISO 13485:2016 Certified and has an ISO Class 8 (100,000) manufacturing area. The seasoned management team has over 100+ years of combined experience in operations, manufacturing and commercializing propriety medical devices and has a proven track record bringing disruptive technologies to the market.